NCT03115307View on ClinicalTrials.gov

Luteal Phase Support in Insemination Cycles

PHASE4CompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Infertility, Female
Interventions
DRUG

Triptorelin

Triptorelin 0,1mg/ml subcutaneously once in a luteal phase in insemination cycles.

Trial Locations (1)

Unknown

Tampere University Hospital, Tampere

All Listed Sponsors
lead

Tampere University Hospital

OTHER

NCT03115307 - Luteal Phase Support in Insemination Cycles | Biotech Hunter | Biotech Hunter